PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
Clinical trial NCT07188610 · RECRUITING
Trial details
- NCT number
- NCT07188610
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2026-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.